Michael J. Galsworthy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Michael J. Galsworthy has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Martin McKee
London School of Hygiene and Tropical Medicine
6 shared publications - Robert Plomin
Social, Genetic and Developmental Psychiatry Centre, King’s College London
5 shared publications Matthias Wismar
European Observatory on Health Systems and Policies, Brussels, Belgium
4 shared publications- Rachel Irwin
Arts and Cultural Sciences, Lund University, Lund, Sweden
4 shared publications Hans-Peter Lipp
Division of Neuroanatomy and Behavior Institute of Anatomy University of Zurich Switzerland
3 shared publicationsKate Charlesworth
3 shared publications
Latest Publications
- Open Access
- 1 October 2014
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (suppl_2)
Country participation for all health-related projects in the EU’s FP5, FP6, and FP7 programmes
Our work and that of others (including the Commission) have repeatedly shown that the newer member states (MS) are consistently under-competitive on the Framework Programmes (FP) in terms of participation and coordination. This is particularly stark for health research with evidence that new MS participation in health research dropped from FP6 to FP7. Furthermore a 6% participation rate of EU-12 countries on FP7 Health was associated with a startlingly low 2.5% share of total financial contribution. Under-funding also occurs on an individual level in many MS, driving “brain drain” from those countries and a downward spiral in competitiveness. Our continuing work explores key correlates of FP participation and national excellence in science and identifies barriers in under-competitive EU MS to personal excellence and inclusion in international projects such as the FP.
- 1 October 2014
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (suppl_2)
Open AccessCountry participation for all health-related projects in the EU’s FP5, FP6, and FP7 programmes
Our work and that of others (including the Commission) have repeatedly shown that the newer member states (MS) are consistently under-competitive on the Framework Programmes (FP) in terms of participation and coordination. This is particularly stark for health research with evidence that new MS participation in health research dropped from FP6 to FP7. Furthermore a 6% participation rate of EU-12 countries on FP7 Health was associated with a startlingly low 2.5% share of total financial contribution. Under-funding also occurs on an individual level in many MS, driving “brain drain” from those countries and a downward spiral in competitiveness. Our continuing work explores key correlates of FP participation and national excellence in science and identifies barriers in under-competitive EU MS to personal excellence and inclusion in international projects such as the FP.
- 1 April 2014
- Published by Elsevier in The Lancet
- Vol. 383 (9924) , 1210
Has Big Pharma hijacked the European health research budget?
- 1 April 2014
- Published by Elsevier in The Lancet
- Vol. 383 (9924) , 1210
Has Big Pharma hijacked the European health research budget?
- 9 July 2013
- Published by Springer Nature
- p. 257-278
Animal Models of General Cognitive Ability for Genetic Research into Cognitive Functioning
- 9 July 2013
- Published by Springer Nature
- p. 257-278
Animal Models of General Cognitive Ability for Genetic Research into Cognitive Functioning
- Open Access
- 1 June 2013
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (3) , 514-520
An analysis of subject areas and country participation for all health-related projects in the EU's FP5 and FP6 programmes
Background: Previous analyses concerning health components of European Union (EU)-funded research have shown low project participation levels of the 12 newest member states (EU-12). Additionally, there has been a lack of subject-area analysis. In the Health Research for Europe project, we screened all projects of the EU’s Framework Programmes for research FP5 and FP6 (1998–2006) to identify health research projects and describe participation by country and subject area. Methods: FP5 and FP6 project databases were acquired and screened by coders to identify health-related projects, which were then categorized according to the 47 divisions of the EU Health Portal (N = 2728 projects) plus an extra group of ‘basic/biotech’ projects (N = 1743). Country participation and coordination rates for projects were also analyzed. Results: Approximately 20% of the 26 946 projects (value €29.2bn) were health-related (N = 4756. Value €6.04bn). Within the health categories, the largest expenditures were cancer (11.9%), ‘other’ (i.e. not mental health or cardiovascular) non-communicable diseases (9.5%) and food safety (9.4%). One hundred thirty-two countries participated in these projects. Of the 27 EU countries (and five partner countries), north-western and Nordic states acquired more projects per capita. The UK led coordination with > 20% of projects. EU-12 countries were generally under-represented for participation and coordination. Conclusions: Combining our findings with the associated literature, we comment on drivers determining distribution of participation and funds across countries and subject areas. Additionally, we discuss changes needed in the core EU projects database to provide greater transparency, data exploitation and return on investment in health research.
- 1 June 2013
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (3) , 514-520
Open AccessAn analysis of subject areas and country participation for all health-related projects in the EU's FP5 and FP6 programmes
Background: Previous analyses concerning health components of European Union (EU)-funded research have shown low project participation levels of the 12 newest member states (EU-12). Additionally, there has been a lack of subject-area analysis. In the Health Research for Europe project, we screened all projects of the EU’s Framework Programmes for research FP5 and FP6 (1998–2006) to identify health research projects and describe participation by country and subject area. Methods: FP5 and FP6 project databases were acquired and screened by coders to identify health-related projects, which were then categorized according to the 47 divisions of the EU Health Portal (N = 2728 projects) plus an extra group of ‘basic/biotech’ projects (N = 1743). Country participation and coordination rates for projects were also analyzed. Results: Approximately 20% of the 26 946 projects (value €29.2bn) were health-related (N = 4756. Value €6.04bn). Within the health categories, the largest expenditures were cancer (11.9%), ‘other’ (i.e. not mental health or cardiovascular) non-communicable diseases (9.5%) and food safety (9.4%). One hundred thirty-two countries participated in these projects. Of the 27 EU countries (and five partner countries), north-western and Nordic states acquired more projects per capita. The UK led coordination with > 20% of projects. EU-12 countries were generally under-represented for participation and coordination. Conclusions: Combining our findings with the associated literature, we comment on drivers determining distribution of participation and funds across countries and subject areas. Additionally, we discuss changes needed in the core EU projects database to provide greater transparency, data exploitation and return on investment in health research.
- Open Access
- 7 May 2013
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 18 (3) , 182-185
Europe's ‘Horizon 2020’ science funding programme: how is it shaping up?
Over the past 15 years, the European Union (EU) has spent around €80 billion on science research via Framework Programmes (FP5, FP6 and FP7). In 2014, a new programme, Horizon 2020, will likely invest another €70 billion over 6 years. Health research has been a major part: between 12% and 17% was spent on official FP5 and FP6 health research lines, although our work categorizing all EU science projects puts the health-related investment proportion nearer to 20%. Here, we compare our analyses and experiences with the European Commission's own impact assessments and plans that inform the Horizon 2020 programme. Much is moving in the right direction but some key gaps are overlooked. We discuss four areas: red tape, what to fund, harnessing informatics and neglect of Eastern Europe.
- 7 May 2013
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 18 (3) , 182-185
Open AccessEurope's ‘Horizon 2020’ science funding programme: how is it shaping up?
Over the past 15 years, the European Union (EU) has spent around €80 billion on science research via Framework Programmes (FP5, FP6 and FP7). In 2014, a new programme, Horizon 2020, will likely invest another €70 billion over 6 years. Health research has been a major part: between 12% and 17% was spent on official FP5 and FP6 health research lines, although our work categorizing all EU science projects puts the health-related investment proportion nearer to 20%. Here, we compare our analyses and experiences with the European Commission's own impact assessments and plans that inform the Horizon 2020 programme. Much is moving in the right direction but some key gaps are overlooked. We discuss four areas: red tape, what to fund, harnessing informatics and neglect of Eastern Europe.
- Open Access
- 29 October 2012
- Published by Wiley in Anaesthesia
- Vol. 68 (2) , 121-135
Health services research and anaesthesia
- 29 October 2012
- Published by Wiley in Anaesthesia
- Vol. 68 (2) , 121-135
Open AccessHealth services research and anaesthesia
- 1 September 2012
- Published by Elsevier in The Lancet
- Vol. 380 (9846) , 971-972
Academic output of 9 years of EU investment into health research
- 1 September 2012
- Published by Elsevier in The Lancet
- Vol. 380 (9846) , 971-972
Academic output of 9 years of EU investment into health research
- Open Access
- 12 March 2012
- Published by Springer Nature in Nature Precedings
Identifying reliable traits across laboratory mouse exploration arenas: A meta-analysis
This study is a meta-analysis of 367 mice from a collection of behaviour neuroscience and behaviour genetic studies run in the same lab in Zurich, Switzerland. We employed correlation-based statistics to confirm and quantify consistencies in behaviour across the testing environments. All 367 mice ran exactly the same behavioural arenas: the light/dark box, the null maze, the open field arena, an emergence task and finally an object exploration task. We analysed consistency of three movement types across those arenas (resting, scanning, progressing), and their relative preference for three zones of the arenas (home, transition, exploration). Results were that 5/6 measures showed strong individual-differences consistency across the tests. Mean inter-arena correlations for these five measures ranged from +.12 to +.53. Unrotated principal component factor analysis (UPCFA) and Cronbach’s alpha measures showed these traits to be reliable and substantial (32-63% of variance across the five arenas). UPCFA loadings then indicate which tasks give the best information about these cross-task traits. One measure (that of time spent in “intermediate” zones) was not reliable across arenas. Conclusions centre on the use of individual differences research and behavioural batteries to revise understandings of what measures in one task predict for behaviour in others. Developing better behaviour measures also makes sound scientific and ethical sense.
- 12 March 2012
- Published by Springer Nature in Nature Precedings
Open AccessIdentifying reliable traits across laboratory mouse exploration arenas: A meta-analysis
This study is a meta-analysis of 367 mice from a collection of behaviour neuroscience and behaviour genetic studies run in the same lab in Zurich, Switzerland. We employed correlation-based statistics to confirm and quantify consistencies in behaviour across the testing environments. All 367 mice ran exactly the same behavioural arenas: the light/dark box, the null maze, the open field arena, an emergence task and finally an object exploration task. We analysed consistency of three movement types across those arenas (resting, scanning, progressing), and their relative preference for three zones of the arenas (home, transition, exploration). Results were that 5/6 measures showed strong individual-differences consistency across the tests. Mean inter-arena correlations for these five measures ranged from +.12 to +.53. Unrotated principal component factor analysis (UPCFA) and Cronbach’s alpha measures showed these traits to be reliable and substantial (32-63% of variance across the five arenas). UPCFA loadings then indicate which tasks give the best information about these cross-task traits. One measure (that of time spent in “intermediate” zones) was not reliable across arenas. Conclusions centre on the use of individual differences research and behavioural batteries to revise understandings of what measures in one task predict for behaviour in others. Developing better behaviour measures also makes sound scientific and ethical sense.
- 1 January 2011
- Published by Elsevier in Experimental Neurology
- Vol. 227 (1) , 42-52
The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia
- 1 January 2011
- Published by Elsevier in Experimental Neurology
- Vol. 227 (1) , 42-52
The puzzle box as a simple and efficient behavioral test for exploring impairments of general cognition and executive functions in mouse models of schizophrenia
- 1 July 2010
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 15 (3) , 133-136
Difficulties of tracing health research funded by the European Union
Objective: European Union (EU) information from research projects, including key findings, should be available on the European Commission's Community Research and Development Information Service (CORDIS) database. We describe the results of the Health Research for Europe (HR4E) project which aimed to synthesize results of health research from the EU's Fifth and Sixth Framework Programmes (FP5 and FP6) of research. Methods: Screening of titles and abstracts of all projects funded within FP5 and FP6 to identify health-related projects followed by allocation of such projects to one of the 47 themes of the European Union's Health Portal. Extraction of key findings relevant for policy and practice from data on the CORDIS database and, in a subset of 182 projects selected from five themes, attempted contact with project co-ordinators to obtain missing information. Results: The information held on CORDIS was inadequate, with many fields not completed. Data were rarely updated after the project had been funded. Of the 182 attempts to contact co-ordinators, useful information was obtained in only 17% of cases, with many contact details missing or unverifiable. Conclusions: CORDIS does not meet its stated objectives of facilitating and disseminating EU research. There is a clear need to review the systems designed to manage the CORDIS platform.
- 1 July 2010
- Published by SAGE Publications in Journal of Health Services Research & Policy
- Vol. 15 (3) , 133-136
Difficulties of tracing health research funded by the European Union
Objective: European Union (EU) information from research projects, including key findings, should be available on the European Commission's Community Research and Development Information Service (CORDIS) database. We describe the results of the Health Research for Europe (HR4E) project which aimed to synthesize results of health research from the EU's Fifth and Sixth Framework Programmes (FP5 and FP6) of research. Methods: Screening of titles and abstracts of all projects funded within FP5 and FP6 to identify health-related projects followed by allocation of such projects to one of the 47 themes of the European Union's Health Portal. Extraction of key findings relevant for policy and practice from data on the CORDIS database and, in a subset of 182 projects selected from five themes, attempted contact with project co-ordinators to obtain missing information. Results: The information held on CORDIS was inadequate, with many fields not completed. Data were rarely updated after the project had been funded. Of the 182 attempts to contact co-ordinators, useful information was obtained in only 17% of cases, with many contact details missing or unverifiable. Conclusions: CORDIS does not meet its stated objectives of facilitating and disseminating EU research. There is a clear need to review the systems designed to manage the CORDIS platform.